Product Name
NCI-H929 Cell Line
Expression System
Mammalian Expression System
Concentration
Approximately 5 × 106 cells/vial
Application
This in vivo validated tumor cell line is designed for tumor modeling and preclinical evaluation of anticancer therapies. It enables assessment of tumor formation, growth kinetics, and therapeutic response in established models, and can be used for efficacy studies, pharmacological evaluation, and mechanism-of-action investigations in oncology research.
Growth Conditions
1640 + 20% FBS
Growth Properties
Half-adherent
Mycoplasma Status
Negative
Storage
90 % FBS + 10 % DMSO
Vapor phase of liquid nitrogen
Shipping Conditions
Dry Ice
Description
Curve of NCI-H929 (human myeloma) cell subcutaneous tumor formation in mice.
Tumor bearing: Subcutaneous injection of 1 × 107 NCI-H929 cells into the right back of mouse.
Strain: NOD/SCID mouse (Female, 6-8W, N=6)
Administration node: D8
Industry Terms
Not Available to Industry
